Technetium Tc 99m Medronate
"Technetium Tc 99m Medronate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.
| Descriptor ID |
D013669
|
| MeSH Number(s) |
D02.691.825.750 D02.705.429.500.885
|
| Concept/Terms |
Technetium Tc 99m Medronate- Technetium Tc 99m Medronate
- Tc-99 Medronate
- Medronate, Tc-99
- Tc 99 Medronate
- Technetium Methylene Diphosphonate
- Diphosphonate, Technetium Methylene
- Methylene Diphosphonate, Technetium
- Technetium Tc 99m Methylenediphosphonate
- 99mTc-Methylene Diphosphonate
- 99mTc Methylene Diphosphonate
- Diphosphonate, 99mTc-Methylene
- 99mTc-MDP
- Tc-99m MDP
- Tc-99m Methylene Diphosphonate
- Diphosphonate, Tc-99m Methylene
- Methylene Diphosphonate, Tc-99m
- Tc 99m Methylene Diphosphonate
|
Below are MeSH descriptors whose meaning is more general than "Technetium Tc 99m Medronate".
Below are MeSH descriptors whose meaning is more specific than "Technetium Tc 99m Medronate".
This graph shows the total number of publications written about "Technetium Tc 99m Medronate" by people in this website by year, and whether "Technetium Tc 99m Medronate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technetium Tc 99m Medronate" by people in Profiles.
-
Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer. Nucl Med Commun. 2019 Sep; 40(9):940-946.
-
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology. BMJ Case Rep. 2019 Apr 23; 12(4).
-
Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223. Adv Exp Med Biol. 2014; 804:291-304.
-
The incremental value of SPECT/CT in characterizing solitary spine lesions. J Nucl Med Technol. 2011 Sep; 39(3):201-7.
-
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer. Clin Cancer Res. 2010 Dec 15; 16(24):6093-9.
-
Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol. 2008 Aug; 38(8):841-7.
-
Compartment syndrome caused by computed tomography contrast infiltration seen on a Tc-99m methylene diphosphonate bone scan. Clin Nucl Med. 2008 Jan; 33(1):36-7.
-
Tc-99m MDP bone scintigraphy and positron emission tomography/computed tomography (PET/CT) imaging in Erdheim-Chester disease. Clin Nucl Med. 2007 Jan; 32(1):35-8.
-
The efficacy of cylindrical titanium mesh cage for the reconstruction of a critical-size canine segmental femoral diaphyseal defect. J Orthop Res. 2006 Jul; 24(7):1438-53.
-
Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease. Am J Ophthalmol. 2001 Dec; 132(6):945-7.